{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:27:41Z","timestamp":1790357261422,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1202246"],"award-info":[{"award-number":["OPP1202246"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtm.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T03:48:45Z","timestamp":1615434525000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["In\u00a0vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-9568","authenticated-orcid":false,"given":"Magnus A.G.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-3819","authenticated-orcid":false,"given":"Collin","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-3990","authenticated-orcid":false,"given":"Pamela J.","family":"Bjorkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.03.003_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fphys.2019.01070","article-title":"Red blood cell membrane processing for biomedical applications","volume":"10","author":"Rossi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2021.03.003_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tmrv.2016.08.004","article-title":"Erythrocytes as carriers for drug delivery in blood transfusion and beyond","volume":"31","author":"Villa","year":"2017","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.omtm.2021.03.003_bib3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.03.003_bib4","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1073\/pnas.88.10.4409","article-title":"Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus","volume":"88","author":"Zeira","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0005-2736(91)90332-3","article-title":"Functional expression of the CD4 protein after cross-linking to red blood cells with a bifunctional reagent","volume":"1062","author":"Idziorek","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.03.003_bib6","doi-asserted-by":"crossref","first-page":"12897","DOI":"10.1073\/pnas.0506211102","article-title":"The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection","volume":"102","author":"Asher","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40709-018-0075-5","article-title":"Bone marrow stem cells to destroy circulating HIV: a hypothetical therapeutic strategy","volume":"25","author":"Halder","year":"2018","journal-title":"J.\u00a0Biol. Res. (Thessalon.)"},{"key":"10.1016\/j.omtm.2021.03.003_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/mt.2012.46","article-title":"Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in\u00a0vivo","volume":"20","author":"Herbst","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2021.03.003_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2016-09-741835","article-title":"Widespread and dynamic translational control of red blood cell development","volume":"129","author":"Alvarez-Dominguez","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.03.003_bib10","doi-asserted-by":"crossref","first-page":"eaan0218","DOI":"10.1126\/science.aan0218","article-title":"UBE2O remodels the proteome during terminal erythroid differentiation","volume":"357","author":"Nguyen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.03.003_bib11","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1073\/pnas.1409861111","article-title":"Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes","volume":"111","author":"Shi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41467-017-00448-0","article-title":"Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.03.003_bib13","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1128\/JVI.75.8.3779-3790.2001","article-title":"CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T\u00a0cells","volume":"75","author":"Singer","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2021.03.003_bib14","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1128\/JVI.76.10.4709-4722.2002","article-title":"Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4+ T\u00a0cells","volume":"76","author":"Popik","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2021.03.003_bib15","first-page":"67930","article-title":"\u03b2-globin gene transfer to human bone marrow for sickle cell disease","author":"Romero","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.03.003_bib16","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.96.9.5215","article-title":"Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages","volume":"96","author":"Lee","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt745","article-title":"A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes","volume":"20","author":"Cavrois","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2021.03.003_bib18","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1073\/pnas.1507712112","article-title":"O-glycans direct selectin ligands to lipid rafts on leukocytes","volume":"112","author":"Shao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib19","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2005","journal-title":"Curr. Protoc. Immunol"},{"key":"10.1016\/j.omtm.2021.03.003_bib20","doi-asserted-by":"crossref","first-page":"18719","DOI":"10.1073\/pnas.2010320117","article-title":"Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells","volume":"117","author":"Hoffmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib21","doi-asserted-by":"crossref","first-page":"e77756","DOI":"10.1371\/journal.pone.0077756","article-title":"Detection of HIV-1 neutralizing antibodies in a human CD4+\/CXCR4+\/CCR5+ T-lymphoblastoid cell assay system","volume":"8","author":"McLinden","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2021.03.003_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1461-0248.2006.01013.x","article-title":"Virus population extinction via ecological traps","volume":"10","author":"Dennehy","year":"2007","journal-title":"Ecol. Lett."},{"key":"10.1016\/j.omtm.2021.03.003_bib23","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1038\/ncomms14750","article-title":"An immortalized adult human erythroid line facilitates sustainable and scalable generation of functional red cells","volume":"8","author":"Trakarnsanga","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.03.003_bib24","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.3324\/haematol.2019.229211","article-title":"Comparing the two leading erythroid lines BEL-A and HUDEP-2","volume":"105","author":"Daniels","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.03.003_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2021.03.003_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2021.03.003_bib27","doi-asserted-by":"crossref","first-page":"E440","DOI":"10.3390\/pharmaceutics12050440","article-title":"Vascular drug delivery using carrier red blood cells: focus on RBC surface loading and pharmacokinetics","volume":"12","author":"Glassman","year":"2020","journal-title":"Pharmaceutics"},{"issue":"Pt A","key":"10.1016\/j.omtm.2021.03.003_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2021.03.003_bib29","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1073\/pnas.94.14.7566","article-title":"Chemical camouflage of antigenic determinants: stealth erythrocytes","volume":"94","author":"Scott","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/02652048.2011.629741","article-title":"Surface-modified loaded human red blood cells for targeting and delivery of drugs","volume":"29","author":"Sternberg","year":"2012","journal-title":"J.\u00a0Microencapsul."},{"key":"10.1016\/j.omtm.2021.03.003_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-020-00644-2","article-title":"Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases","author":"Zhao","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtm.2021.03.003_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt846","article-title":"Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes","volume":"21","author":"Murciano","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2021.03.003_bib33","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.03.003_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/bloodadvances.2017011734","article-title":"Biocompatible coupling of therapeutic fusion proteins to human erythrocytes","volume":"2","author":"Villa","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2021.03.003_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1096\/fj.201600912R","article-title":"Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury","volume":"31","author":"Carnemolla","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2021.03.003_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/157016207781024018","article-title":"Rev-dependent indicator T\u00a0cell line","volume":"5","author":"Wu","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.omtm.2021.03.003_bib37","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2011-06-362038","article-title":"Proof of principle for transfusion of in\u00a0vitro-generated red blood cells","volume":"118","author":"Giarratana","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.03.003_bib38","doi-asserted-by":"crossref","first-page":"e1500112","DOI":"10.1126\/sciadv.1500112","article-title":"Engineered binding to erythrocytes induces immunological tolerance to E.\u00a0coli asparaginase","volume":"1","author":"Lorentz","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2021.03.003_bib39","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.03.003_bib40","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","article-title":"Cellular nanosponges inhibit SARS-CoV-2 infectivity","volume":"20","author":"Zhang","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtm.2021.03.003_bib41","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1182\/blood-2011-12-398149","article-title":"Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis","volume":"119","author":"Zaitsev","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.03.003_bib42","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.4049\/jimmunol.148.8.2462","article-title":"In\u00a0vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor","volume":"148","author":"Taylor","year":"1992","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2021.03.003_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nature20607","article-title":"Designed proteins induce the formation of nanocage-containing extracellular vesicles","volume":"540","author":"Votteler","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.03.003_bib44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/j.1460-2075.1994.tb06337.x","article-title":"Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein","volume":"13","author":"Ryan","year":"1994","journal-title":"EMBO J."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:26:14Z","timestamp":1762421174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":44,"alternative-id":["S2329050121000437"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.20.423607","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}